Allianz Asset Management »

Urogen Pharma shares owned by Allianz Asset Management

Quarter-by-quarter ownership of Urogen Pharma (URGN) shares owned by Allianz Asset Management from 13F filings

Historical chart of Allianz Asset Management investment in Urogen Pharma

Tip: Access up to 7 years of quarterly data

All positions including Urogen Pharma held by Allianz Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Urogen Pharma by Allianz Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $439k 22k 19.95
2025-06-30 $203k 15k 13.70

More positions owned by Allianz Asset Management

Venture Global Com Cl A (VG)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Johnson & Johnson (JNJ)
Ishares Tr Msci Emg Mkt Etf (EEM)
JPMorgan Chase & Co. (JPM)
Vici Pptys (VICI)
Cisco Systems (CSCO)

View all positions for Allianz Asset Management

Top funds holding Urogen Pharma

Rtw Investments
Paradigm Biocapital Advisors
Toronto-Dominion Bank
BlackRock
Morgan Stanley
Leucadia National Corporation
Silverarc Capital Management
Millennium Management
Acorn Capital Advisors
SG Americas Securities
Menora Mivtachim Holdings
Caption Management
Tang Capital Management
D. E. Shaw & Co
State Street Corporation

View all funds holding Urogen Pharma